Dendritic cells present in negative SLN appear to be more tolerogenic than those within the primary tumour because, although the median expression of ILT3 remains stable, the expression of both IDO and TGFβ1 increases by as much as a factor of 30 in matched samples. The gene discussed is TGFB1; the disease is neoplasm.